首页> 外文期刊>Journal of Pathology: Journal of the Pathological Society of Great Britain and Ireland >Comparison of the immunophenotypes of signet-ring cell carcinoma, solid adenocarcinoma with mucin production, and mucinous bronchioloalveolar carcinoma of the lung characterized by the presence of cytoplasmic mucin.
【24h】

Comparison of the immunophenotypes of signet-ring cell carcinoma, solid adenocarcinoma with mucin production, and mucinous bronchioloalveolar carcinoma of the lung characterized by the presence of cytoplasmic mucin.

机译:比较印戒细胞癌,具有粘蛋白产生的实体腺癌和肺粘液性支气管肺泡癌的免疫表型,其特征在于存在胞质粘蛋白。

获取原文
获取原文并翻译 | 示例
           

摘要

The latest World Health Organization (WHO) classification divides adenocarcinoma mainly into adenocarcinoma mixed subtypes, acinar adenocarcinoma, papillary adenocarcinoma, bronchioloalveolar carcinoma, and solid adenocarcinoma with mucin production, and it mentions several variants, including fetal adenocarcinoma, mucinous ("colloid") adenocarcinoma, mucinous cystadenocarcinoma, signet-ring adenocarcinoma, and clear cell adenocarcinoma. In general, the mucin-producing adenocarcinoma of the lung comprises signet-ring cell carcinoma (SRCC), solid adenocarcinoma with mucin production (SA), and mucinous bronchioloalveolar carcinoma (m-BAC), mucinous ("colloid") adenocarcinomas and/or mucinous cystadenocarcinoma, and mucoepidermoid carcinoma. As SRCC, SA, and m-BAC exhibit distinct clinical features, it is important to identify differences in their immunohistochemical characteristics to better understand their histogenesis. In this study we analysed SRCC, SA, m-BAC, normal lung, and foregut-related secretory tissue for immunohistochemical differences using tissue microarrays. SRCC and SA showed high expression of MUC1 (97.4% and 100%, respectively), cytokeratin (CK) 7 (both 100%), and thyroid transcription factor-1 (TTF-1) (81.1% and 100%, respectively). They also showed low expression of MUC5AC (25.5% and 21.1%, respectively) and MUC6 (18.3% and 10.5%, respectively), whereas m-BAC showed high expression of MUC5AC (97.5%), MUC6 (75.0%), and CK7 (94.7%), but low expression of MUC1 (57.5%), and TTF-1 (27.5%). Hierarchical clustering showed that the immunophenotypes of SRCC and SA belong to the same category as alveolar lining cells, whereas m-BAC clustered onto another branch with gastric foveolar cells and bronchial goblet cells. These immunohistochemical findings support the results of our previous clinicopathological analysis of SRCC of the lung showing that SRCC occurs anatomically in the peripheral portion of the lung rather than in the bronchial gland-bearing portion. Published by John Wiley & Sons, Ltd.
机译:世界卫生组织(WHO)最新的分类将腺癌主要分为以下几种:腺癌混合亚型,腺泡腺癌,乳头状腺癌,细支气管肺泡癌和产生黏液的实体腺癌,并提到了几种变体,包括胎儿腺癌,黏液腺癌(“胶体”) ,粘液性囊腺癌,印戒腺癌和透明细胞腺癌。通常,肺中产生粘蛋白的腺癌包括印戒细胞癌(SRCC),产生粘蛋白的实体腺癌(SA),粘液性细支气管肺泡癌(m-BAC),粘液性(“胶体”)腺癌和/或粘液性囊腺癌和粘液表皮样癌。由于SRCC,SA和m-BAC具有明显的临床特征,因此重要的是要鉴定其免疫组织化学特征的差异,以更好地了解其组织发生。在这项研究中,我们使用组织芯片分析了SRCC,SA,m-BAC,正常肺和前肠相关的分泌组织的免疫组织化学差异。 SRCC和SA显示MUC1(分别为97.4%和100%),细胞角蛋白(CK)7(均为100%)和甲状腺转录因子-1(TTF-1)(分别为81.1%和100%)的高表达。它们还显示MUC5AC(分别为25.5%和21.1%)和MUC6(分别为18.3%和10.5%)的低表达,而m-BAC显示MUC5AC(97.5%),MUC6(75.0%)和CK7的高表达。 (94.7%),但MUC1(57.5%)和TTF-1(27.5%)的低表达。分层聚类表明,SRCC和SA的免疫表型与肺泡内膜细胞属于同一类别,而m-BAC聚簇到另一个具有胃小泡细胞和支气管杯状细胞的分支上。这些免疫组织化学结果支持了我们先前对肺SRCC进行临床病理分析的结果,表明SRCC在解剖学上发生在肺的外围部分,而不是在支气管腺体部分。由John Wiley&Sons,Ltd.出版

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号